Active Music-Based Intervention in Patients With Chronic Low Back Pain
Launched by SHARON WANG-PRICE · Apr 18, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how active music-based activities can help people who have chronic low back pain, which is pain that lasts for more than three months. Researchers want to find out if these music activities can improve memory and thinking, change how people feel pain, reduce negative thoughts about pain, and overall make life better for participants.
To participate, you need to be between 18 and 65 years old and have low back pain mainly in the lower back area (specifically around the L4-5 vertebrae) for at least three months. If you qualify, you'll come to the clinic for five visits over two weeks. The first visit will involve some assessments followed by a 45-minute music session, and the next four visits will include an hour of active music activities. After the last session, you’ll have a short assessment to see how things have changed. This study is not yet recruiting participants, so keep an eye out for updates if you're interested!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adults 18-65 years of age
- • have chronic low back pain (CLBP) primarily in the L4-5 area. The CLBP is defined as a back pain problem that has persisted at least 3 months and has resulted in pain on at least half the days in the past 6 months.
- Exclusion Criteria:
- Participants will be excluded if their low back pain (LBP) is due to a non-musculoskeletal origin or they have any medical conditions that may affect the results:
- • Previous back surgery
- • Systemic arthritis (e.g., rheumatoid arthritis, psoriatic arthritis).
- • Fracture of thoracic and lumbar spine, pelvis
- • Infection
- • Tumor
- • Traumatic brain injury
- • Stroke
- • Seizures/epilepsy
- • Any other neurological disease (e.g., multiple sclerosis, muscular dystrophy, - Parkinson's)
- • Circulation/vascular problems (e.g., Raynaud's)
- • Cancer
- • Uncontrolled diabetes/high blood sugar
- • Currently pregnant
About Sharon Wang Price
Sharon Wang-Price is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on rigorous scientific methodology and ethical standards, she leads initiatives that explore novel therapies and treatment pathways in various therapeutic areas. Her expertise in clinical development and regulatory affairs ensures that trials are conducted efficiently and in compliance with industry standards. Sharon's collaborative approach fosters strong partnerships with research institutions and healthcare professionals, driving the successful execution of clinical trials that aim to enhance healthcare solutions and benefit patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Sharon Wang-Price, PhD
Principal Investigator
Texas Woman's University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported